Acute Pancreatitis in a Child with Sickle Cell Disease

Author Infromation

Ehab Hanafy1, Fadwa Abufara2, Norah Alotaibi2, Manal Albalawi2, Doha Abuharfil2, Mustafa Altoonisi2, Gihan Mahmoud1

1 Prince Sultan Oncology Center, King Salman Armed Forces Hospital, Tabuk, SAU

2 Pediatrics Department, King Salman Armed Forces Hospital, Tabuk, SAU

Sickle cell disease (SCD) is one of the common hemoglobinopathies around the world. It is characterized by a wide spectrum of complications that vary in severity. Vaso-occlusive crisis is the most common complication and accounts for the majority of admissions, while acute chest syndrome and sepsis are responsible for most of sickle cell-related mortalities. One of the commonly affected systems is the hepatobiliary system which can be either directly affected through the sickling process or indirectly as a result of chronic haemolysis and multiple blood transfusions. Clinical manifestations range from benign hyper-bilirubinaemia to liver failure, and this harbours diagnostic and therapeutic dilemmas to the treating physicians (1). Acute pancreatitis is one of the most common causes of acute abdominal pain necessitating hospital admission. It is not a common association with SCD but can be seen as a result of cholelithiasis due to common bile duct obstruction (2). Nevertheless, there are reports of pancreatitis in SCD patients without cholelithiasis and this can be attributed to microvascular occlusions or ischemic injury (3). Manifestations range from mild to severe, and treatment remains largely conservative with the use of hydration, analgesics and antibiotics. Cholecystectomy is reserved for cases of pancreatitis associated with gallstones, while exchange transfusion may be the procedure of choice in patients with severe ischemic pancreatitis (4).

This is a 7-year-old boy known to have SCD, presented to the emergency room with abdominal pain and vomiting for 1-day, abdominal pain started in the morning as moderate persistent epigastric pain, with no radiation, associated with non-projectile, non-bilious vomiting, poor oral intake, and mild lower limb pain. There was no fever, no pallor or jaundice, no change in urine amount or character, no constipation or diarrhoea. No history of trauma, no recent or concurrent illness, no history of recent travel.

He was diagnosed as SCD at the age of 1year. Both parents are consanguineous and have sickle cell trait; one sibling was diagnosed with sickle cell trait. He has history of bronchial asthma and is on Ventolin as needed. There was no history of hypertension, diabetes or other conditions of medical concerns; he had no history of any surgical interventions. There was no history of drug allergies. Developmental history is compatible with his age and vaccination is up to date. He was on regular follow up at our pediatric haematology clinic and on regular hydroxyurea and folic acid supplements. His chronic condition was overall uncomplicated, last time he was admitted was 2 months earlier for an attack of haemolytic crises, when he received blood transfusion. No major complications of sickle cell anaemia (stroke, splenic sequestration, osteomyelitis, or acute chest syndrome), no history of previous blood exchange.

On examination, he was a febrile 37.4oc, not distressed, oxygen saturation was 97% on room air, respiratory rate (24/min), heart rate (84 beats/min), blood pressure was normal for age (120/70). Chest examination showed no signs of distress, clear and equal air entry bilaterally, no wheezing, and no crepitations. Cardiovascular examination revealed good perfusion, good peripheral pulses, normal heart sounds and no detected murmurs. Abdomen was not distended, soft, lax, with mild tenderness on the epigastric area, no organomegaly, and there were audible bowel sounds. He was awake, alert, oriented, GCS 15/15, equal and normal tone, power and reflexes bilaterally. There was no skin rash, no limb tenderness, no joints swelling, and no limitation of movement. His initial blood work results on admission showed elevated white blood cells, markedly elevated serum amylase and lipase. See (Table-1) for full blood work.

From the clinical and laboratory data mentioned above, a primary diagnosis of acute ischemic pancreatitis associated with SCD was suggested. The patient was admitted to the pediatric intensive care (PICU) for close observation. We decided to perform an urgent CT abdomen and start the process of exchange blood transfusion. Surgical consultation was considered if the patient developed signs of intestinal obstruction, silent abdomen or increased abdominal tenderness. The child was kept NPO on IV fluids, started on IV Antibiotics (Teicoplanin, Cefotaxime, and Metronidazole). Right femoral central line was inserted, and blood exchange took place 7 hours after admission.

Abdominal CT with IV contrast showed swollen pancreas with peripancreatic and retroperitoneal fluid seen at the retro mesenteric plane, left latero-conal plane and left retro-renal plane. No pancreatic necrosis, no collection. Signs suggestive of acute pancreatitis. There was mild splenomegaly, liver was normal, and no gall stones detected (Fig-1). On the next day, the patient was shifted from PICU in a stable condition with marked improvement. He was monitored for 3 more days then was discharged home. His repeated lab results are shown in (Table-2) and (Fig-2).

Table-1
Blood work at the time of presentation
Table-2
Blood work at the time of discharge
Fig-1
CT abdomen showed swollen pancreas.
Fig-2
Pattern of amylase and lipase levels during 4 days of admission and at day 15 follow up.
Fig-3
Prevalence of hepatobiliary complications in children with SCD (19).

Discussion

Sickle cell disease is one of the most common hereditary haemolytic anaemias in Saudi Arabia. It is caused by mutation in the beta globin chain that results in abnormal haemoglobin S which is polymerized with deoxygenation. This will ultimately lead to increased deformability and rigidity of red blood cells (5). Interruption of tissue perfusion and ischemia occurs through oxidative damage of red cells and activation of coagulation pathways, accumulation of free haemoglobin in plasma after intravascular haemolysis which in turn consumes nitric oxide where its depletion will cause vascular endothelial dysfunction and vasoconstriction. The result will be decreased blood flow and hypoxia with further damage to the endothelium (6). Moreover, damaged endothelium leads to expression of adherent proteins on the endothelial surface, facilitating its adherence to white and red blood cells. With continuous hypoxia and reperfusion, acute and chronic vascular injury occurs that may end up with organ failure (7). The major features and manifestations of SCD are related to haemolysis and Vaso-occlusion. There is wide spectrum of manifestations that vary in severity and includes acute painful crisis, haemolytic crisis, aplastic crisis, acute chest syndrome, hepatobiliary and neurologic disorders.

Besides acute pancreatitis, which is the focus of this article, there are other hepatobiliary manifestations of SCD that are more common (8). For instance, biliary sludge; a composited material of bile mucus and embedded crystals which is asymptomatic in most cases but holds a high risk of developing into stones of the gallbladder and biliary tree. In which case, the treatment of choice would be laparoscopic cholecystectomy (9). Another distinct manifestation is sickle cell cholangiopathy, where the cholestatic jaundice is paired with dilatation of the bile ducts but without any evidence of obstruction. However, when cholestatic jaundice is accompanied by elevated liver enzymes then hepatic involvement is most certain (10). Furthermore, the liver reacts to intrahepatic sickling in varying degrees ranging from self-limiting acute sickle cell hepatic crises to hepatic sequestration crisis. This is characterized by significant drop of haemoglobin and reticulocytosis which ends up with the most critical hepatic complication in form of intrahepatic cholestasis with more pronounce elevation of the transaminases and serum bilirubin (11). Finally, the need for frequent blood transfusions in certain circumstances carries the risk of conducting hepatitis B and C resulting in further hepatic complications (12), see (Fig-3).

Hepatobiliary complications of SCD present with different manifestations, however when acute abdominal pain is the main presentation, diagnosis can be further challenging. Other than sickle cell-related crisis, the possibilities are ranging from simple abdominal colic to acute appendicitis, splenic abscess, acute intestinal obstruction. Other less common causes include enlarged retroperitoneal lymph nodes, mesenteric artery thrombosis, and vertebral body infarctions (13). In one Nigerian study conducted over 10 years, there had been 6 patients with SCD who presented with acute abdomen and had surgical operation performed, two of those had appendicitis, two had cholecystitis, one had splenic abscess, and the sixth one had acute intestinal obstruction (14). Having known this wide variety of diagnoses, a thorough history and physical examination paired with adequate utilization of laboratory and imaging studies are crucial in the management of SCD patients presenting with acute abdominal pain.

The exact prevalence of pancreatitis in SCD is not known. One study revealed a 7% prevalence rate among adult patients with SCD, where more than 70% of cases are associated with gallstones as an etiologic factor. Other causes included alcoholic use and bowel obstruction. Sparse data is available in the literature regarding the prevalence in children with SCD (15). Ahmed et al. reported a series of four SCD patients who developed acute pancreatitis, one of them was a pediatric patient. All the patients received conservative management, while 3 out of 4 patients received several blood transfusions and none had exchange transfusion. An important point to consider is that all patients showed improvement only several days after initiation of management. In our reported case, there was a dramatic clinical and laboratory improvement one day following exchange transfusion (16). Another report by Hasan et al. who described an adult SCD patient with acute pancreatitis, the patient was shocked and required inotropes, however a marked improvement was noted only few hours post exchange transfusion that brought down the HB S level from 60% to 18% (17). In 1993, a pediatric SCD patient with pancreatitis was reported by Sheehan et al. who showed improvement few days after admission and had normal pancreatic enzymes level in 4-weeks period. The child received no blood transfusion nor had an exchange (18). Given the current limited data on the prevalence and management of pancreatitis in children with SCD, it is hard to define a standard of care rather than the conservative management used for general population. Nevertheless, it seems that exchange transfusion and lowering the HB S level have an impact on the rapid recovery of such patients. Available data suggests the use of exchange transfusion in serious illnesses and in patients with sickle cell related organ failure. Knowing the leading etiology of acute pancreatitis might outline the management plan, for instance, causes due to microvascular occlusion or ischemia can hopefully benefit from exchange transfusion.

Conclusion

Significant attention should be given to SCD patients presenting with acute abdomen. Acute pancreatitis with or without cholelithiasis is a rare but serious cause. Subsequent tailoring of care based on unique patient’s characteristics remains crucial to maximizing outcomes. Exchange blood transfusion versus conservative management should be studied on large scale of patients to set up a clear guideline in case of pancreatitis occurring in patients with SCD.

References

  1. Shah R, Taborda C, Chawla S. Acute and chronic hepatobiliary manifestations of sickle cell disease: A review. World J Gastrointest Pathophysiol 2017;8:108.
  2. Lankisch P, Apte M, Banks P. Acute pancreatitis. The Lancet 2015;386:85-96.
  3. Moori P, Dosis A, Ahmad Z, Kausar A, Triantafyllopoulou D. Acute pancreatitis as a complication of sickle cell anaemia. Reports 2018;1:19.
  4. Ziegler D, Long J, Philippart A, Klein M. Pancreatitis in childhood. Ann Surg 1988;207:257-61.
  5. Steinberg M. Pathophysiology of sickle cell disease. Baillière’s Clinical Haematology 1998;11:163-84.
  6. Nathan D, Oski F, Orkin S. Nathan and Oski’s hematology and oncology of infancy and childhood. Philadelphia, Pa: Elsevier Saunders; 2015.
  7. Sundd P, Gladwin M, Novelli E. Pathophysiology of sickle cell disease. Annual Review of Pathology: Mechanisms of Disease 2019; 14:263-92.
  8. Issa H. Hepatobiliary manifestations of sickle cell anemia. Gastroenterology Res 2010;3:1-8.
  9. Bond L, Hatty S, Horn M, Dick M, Meire H, Bellingham A. Gall stones in sickle cell disease in the United Kingdom. BMJ 1987;295:234-6.
  10. Al-Salem A, Nangalia R, Kolar K, Qaisaruddin S, Al-Dabbous I, Al-Jam’a A. Cholecystectomy in children with sickle-cell disease. Pediatr Surg Int 1995;10:472.
  11. Hillaire S, Gardin C, Attar A et al. Cholangiopathy and intrahepatic stones in sickle cell disease: coincidence or ischemic cholangiopathy?. Am J Gastroenterol 2000;95:300
  12. Johnson C, OmataM, Tong M, Simmons J, Weiner J, Tatter D. Liver involvement in sickle cell disease. Medicine (Baltimore) 1985;64:349.
  13. Arya R, Wade J, Stephens A. An unusual cause of abdominal pain in sickle cell disease. Blood 1998;92:3477-8.
  14. Jebbin N, Adotey J. Acute abdominal conditions in people with sickle cell disease: A 10-year experience in Port Harcourt, Nigeria. Ann Afr Med 2011;10:165.
  15. Jasti S, Williams V, Vamadevan A, Gillette P, Gress F. Prevalence of acute pancreatitis in sickle cell disease. American Journal of Gastroenterology 2008;103:S91-S92.
  16. Ahmed S, Siddiqui A, Siddiqui R, Kimpo M, Russo L, Mattana J. Acute pancreatitis during sickle cell vaso-occlusive painful crisis. Am J Hematol 2003;73:190-3.
  17. Hasan B, Asif T, Braun C, Bahaj W, Dosokey E, Pauly R. Pancreatitis in the setting of vaso-occlusive sickle cell crisis: A rare encounter. Cureus 2017;9:e1193.
  18. Sheehan AG, Machida H, Butzner JD. Acute pancreatitis in a child with sickle cell anemia. Journal of the National Medical Association 1993;85:70-2.
  19. Allali S, de Montalembert M, Brousse V et al. Hepatobiliary complications in children with sickle cell disease: Aretrospective review of medical records from 616 patients. J Clin Med 2019;8:1481.

Discover more from Cancer Networks

Subscribe to get the latest posts sent to your email.


Comments

Leave a Reply

Discover more from Cancer Networks

Subscribe now to keep reading and get access to the full archive.

Continue reading